Harthik Parankusham, Casey Vanderlip, Colin Birkenbihl, Eashwar Krishna, Chizobam Ugboaja, Andrew E. Budson et al. A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone. // Annals of Clinical and Translational Neurology. – 2026. – DOI: 10.1002/acn3.70560. – URL: https://onlinelibrary.wiley.com/doi/10.1002/acn3.70560?af=R
Harthik Parankusham, Casey Vanderlip, Colin Birkenbihl, Eashwar Krishna, Chizobam Ugboaja, Andrew E. Budson, Brandon Frank, & for the Alzheimer's Disease Neuroimaging Initiative (2026). A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70560
Harthik Parankusham, et al. “A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone.” Annals of Clinical and Translational Neurology, 2026. doi:10.1002/acn3.70560.
@article{Parankusham2026,
title = {A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone},
author = {Parankusham, Harthik and Vanderlip, Casey and Birkenbihl, Colin and Krishna, Eashwar and Ugboaja, Chizobam and Budson, Andrew E. and Frank, Brandon and Initiative, for the Alzheimer's Disease Neuroimaging},
journal = {Annals of Clinical and Translational Neurology},
year = {2026},
doi = {10.1002/acn3.70560},
url = {https://onlinelibrary.wiley.com/doi/10.1002/acn3.70560?af=R}
}